NCT05936242

Brief Summary

The goal of this observational study is to explore inter- and intra-individual determinants of postprandial glucose response in patients with type 1 diabetes using continous glucose monitoring (CGM). Blood samples and anthropometrics will be collected during hospital visit. Participants will be asked to:

  • record a seven-day food diary
  • complete EPIC food frequency questionnaire
  • complete questionnaires on sleep hygiene
  • collect a stool sample

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
20mo left

Started May 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
May 2021Jan 2028

Study Start

First participant enrolled

May 18, 2021

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

June 30, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 7, 2023

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Last Updated

September 19, 2025

Status Verified

October 1, 2024

Enrollment Period

6.1 years

First QC Date

June 30, 2023

Last Update Submit

September 15, 2025

Conditions

Keywords

Type 1 DiabetesGut MicrobiotaDietary HabitsPostprandial Glucose ResponseHybrid artificial pancreasContinuous Glucose Monitoring

Outcome Measures

Primary Outcomes (1)

  • Postprandial glucose response

    Postprandial glucose response wil be calculated by the trapezoidal method as the area under the curve above the baseline value (iAUC). The association between iAUC and gut microbiota composition derived from the analysis of faeces samples will be assessed. The association between iAUC and energy intake and dietary composition derived from the analysis of 7-days food record and EPIC will be assessed.

    Related to 7-days food record

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of individuals with type 1 diabetes using continuous glucose monitoring (CGM) and regularly attending the Diabetes Outpatient Clinic of Federico II University Teaching Hospital (Naples, Italy).

You may qualify if:

  • Type 1 Diabetes

You may not qualify if:

  • Pregnancy and/or breastfeeding
  • Other chronic or acute diseases
  • Use of antibiotics in the past 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federico II University Hospital

Naples, 80131, Italy

RECRUITING

Related Publications (2)

  • Abuqwider J, Pasolli E, Scida G, Corrado A, Vitale M, De Filippis F, Ercolini D, Annuzzi G, Rivellese AA, Bozzetto L. Gut microbiome profiles and associated functional pathways are linked to Mediterranean diet adherence and blood glucose control in adults with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2025 Dec 2:104487. doi: 10.1016/j.numecd.2025.104487. Online ahead of print.

  • Abuqwider J, Salamone D, Scida G, Corrado A, Costabile G, Luongo D, Annuzzi G, Rivellese A, Bozzetto L. Sex-specific associations of serum short-chain fatty acids with glycaemic control: an Italian cross-sectional study in adults with type 1 diabetes. BMJ Open. 2025 Mar 24;15(3):e096994. doi: 10.1136/bmjopen-2024-096994.

Biospecimen

Retention: SAMPLES WITH DNA

whole blood, buffy coat, feces, serum, and plasma

MeSH Terms

Conditions

Diabetes Mellitus, Type 1Feeding Behavior

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesBehavior, AnimalBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Medical Doctor

Study Record Dates

First Submitted

June 30, 2023

First Posted

July 7, 2023

Study Start

May 18, 2021

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

January 1, 2028

Last Updated

September 19, 2025

Record last verified: 2024-10

Locations